Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Heart Failure: Beyond Y2K -- a Prous Science webcast from the AHA

Nov. 11, 1999

News from AHA: photoangioplasty with Antrin is safe and effective for PAD

Nov. 11, 1999

New HOPE for high-risk patients with cardiovascular disease

Nov. 11, 1999

Novel photosensitizer from Miravant prevents postangioplasty restenosis in pig model

Nov. 10, 1999

News from AHA: Bayer presents promising new treatment for atherosclerosis

Nov. 10, 1999

Vasopeptidase inhibitor steals the show at AHA

Nov. 10, 1999

Levosimendan NDA withdrawn for amendment and subsequent refiling

Nov. 9, 1999

News from AHA: novel MMP inhibitor from P&U effective in CHF model in rats

Nov. 9, 1999

AGI-1067 prevents the progression of atherosclerosis independent of its effects on cholesterol

Nov. 9, 1999

European patents cover novel tricyclic sPLA2 inhibitors designed at Lilly

Nov. 9, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 27, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Chengdu Mfs Pharma synthesizes new compounds for pain
BioWorld Science
Chengdu Mfs Pharma Co. Ltd. has prepared and tested compounds for the potential treatment of pain, sleep disorder and status epilepticus epilepsy as well as for...